| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/07/2011 | WO2011080725A1 Compounds with both analgesic and anti-hyperalgesic efficacy |
| 07/07/2011 | WO2011080722A2 Use of skin permeation and retention enhancer compound in cosmetic and pharmaceutical compositions and cosmetic and pharmaceutical products containing said compound |
| 07/07/2011 | WO2011080706A1 Enhanced solubility of ziprasidone |
| 07/07/2011 | WO2011080704A1 Producing stable adefovir dipivoxil solid dispersions in amorphous state |
| 07/07/2011 | WO2011080691A1 Method for the production of amorphous rifaximin |
| 07/07/2011 | WO2011080683A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs |
| 07/07/2011 | WO2011080570A2 Extended release pharmaceutical composition comprising linezolid and process for preparing the same |
| 07/07/2011 | WO2011080562A1 Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals |
| 07/07/2011 | WO2011080550A1 Curcumin derivatives |
| 07/07/2011 | WO2011080510A1 Tricyclic compounds for use as kinase inhibitors |
| 07/07/2011 | WO2011080488A1 Pharmaceutical composition for treating alcohol dependency |
| 07/07/2011 | WO2011080450A1 Cosmetic or dermatological composition, cosmetic treatment method, and hyaluronic acid derivative |
| 07/07/2011 | WO2011080445A1 Novel (heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors |
| 07/07/2011 | WO2011080444A1 Novel (heterocycle/condensed piperidine)-(piperazinyl)-1-alcanone or (heterocycle/condensed pyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors |
| 07/07/2011 | WO2011080413A1 Enhanced bioavailability solid oral pharmaceutical composition containing a biphosphonic acid or one of the salts thereof |
| 07/07/2011 | WO2011080346A2 Pellets and microparticles of pravastatin sodium and a process of making them |
| 07/07/2011 | WO2011080344A1 Diazoxide for use in the treatment of a central nervous system (cns) autoimmune demyelinating disease |
| 07/07/2011 | WO2011080313A1 Novel piperine derivatives as gaba - a receptors modulators |
| 07/07/2011 | WO2011080277A1 Thieno [2,3-b] pyridinedione activators of ampk and therapeutic uses thereof |
| 07/07/2011 | WO2011080276A1 Pharmaceutical combinations comprising a dpp-4 inhibitor and a 1,3-diphenylprop-2-en-1-one derivative |
| 07/07/2011 | WO2011080269A2 Pharmaceutical preparations comprising a cos releasing compound |
| 07/07/2011 | WO2011080266A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives. |
| 07/07/2011 | WO2011080265A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents |
| 07/07/2011 | WO2011080264A1 New tertiary 8-hydroxyquinoline-7-carboxamide derivatives and uses thereof |
| 07/07/2011 | WO2011080246A1 Oral liquid pharmaceutical composition of nifedipine |
| 07/07/2011 | WO2011080211A1 Pesticidal arylpyrrolidines |
| 07/07/2011 | WO2011080203A1 Sulphated disaccharides for the treatment of neurodegenerative and/or neurovascular diseases |
| 07/07/2011 | WO2011080176A1 Pyrazine derivatives and their use in the treatment of neurological disorders |
| 07/07/2011 | WO2011080148A2 An aqueous intravenous nanosuspension with reduced adverse effects |
| 07/07/2011 | WO2011080139A1 Amino alcohol derivatives and their therapeutic activities |
| 07/07/2011 | WO2011079969A1 A 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative for pharmaceutical use, and the use of a 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative with substantially undefined crystal shape for preparing said 1-(1h-1,2,4-triazol-1-yl)butan-2-ol derivative |
| 07/07/2011 | WO2011079841A1 Beta-carbolines for use in the treatment of hearing loss and vertigo |
| 07/07/2011 | WO2011079817A1 Dendrimer of tuftsin and influenza matrix protein，and use thereof |
| 07/07/2011 | WO2011079807A1 Dipropofol pyrophosphate dihydrogen ester and pharmaceutically acceptable salt, preparation process and application thereof |
| 07/07/2011 | WO2011079804A1 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor |
| 07/07/2011 | WO2011079778A1 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors |
| 07/07/2011 | WO2011079772A1 Method for preparation of 2,5-disubstituted thiophene compound |
| 07/07/2011 | WO2011079767A1 Solid formulation of zopiclone and the preparation method thereof |
| 07/07/2011 | WO2011079766A1 Aripiprazole solid preparation and the production method thereof |
| 07/07/2011 | WO2011079764A1 Solid formulation of eszopiclone and the preparation method thereof |
| 07/07/2011 | WO2011079507A1 Use of pacitaxel and docetaxel |
| 07/07/2011 | WO2011079501A1 Prodrug based on cytarabine structure as well as synthesizing method and application thereof |
| 07/07/2011 | WO2011079494A1 Halogenated dideoxy saccharide derivatives, preparation method and use thereof |
| 07/07/2011 | WO2011079410A1 Medicinal composition including sunflower extract, preparative method and use thereof |
| 07/07/2011 | WO2011079407A1 New compounds having potency to inhibit blood clotting |
| 07/07/2011 | WO2011079349A1 Okadaella gastrococcus and cancer |
| 07/07/2011 | WO2011058373A3 Drug combination with theobromine and its use in therapy |
| 07/07/2011 | WO2011057714A3 Method for preventing the crystallisation of pharmaceuticals in a polymer film |
| 07/07/2011 | WO2011056487A3 Stable thickener formulations |
| 07/07/2011 | WO2011055156A3 Pharmaceutical compositions comprising an estrogen, a gestagen and various copolymers |
| 07/07/2011 | WO2011051966A3 Pharmaceutical compositions for treatment/prophylaxis of non-alcoholic fatty liver disease |
| 07/07/2011 | WO2011051342A8 IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS |
| 07/07/2011 | WO2011039394A3 Use of gymnodimine, analogues and derviatives for the treatment and/or prevention of neurodegenerative diseases associated with tau and b-amyloid |
| 07/07/2011 | WO2011033163A3 Sod-imitating metal complexes |
| 07/07/2011 | WO2011031561A3 Nucleic acid molecules and uses thereof |
| 07/07/2011 | WO2011031099A3 Ursodeoxycholic acid-synthetic hydrotalcite-eudragit hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 07/07/2011 | WO2011028800A3 Treatment of cognitive dysfunction with gangliosides |
| 07/07/2011 | WO2011028799A3 Ganglioside transmucosal formulations |
| 07/07/2011 | WO2011028797A3 Treatment of glaucoma and other retinopathies with gangliosides |
| 07/07/2011 | WO2011021892A3 Composition for skin improvement comprising hexamidines and retinoids |
| 07/07/2011 | WO2011018588A3 Fgf receptor-activating n-acyl octasaccharides, preparation thereof, and therapeutic use thereof |
| 07/07/2011 | WO2011018587A3 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof |
| 07/07/2011 | WO2011017521A4 Bicyclic cyclohexose nucleic acid analogs |
| 07/07/2011 | WO2011017488A3 Combination of a selective ppar-gamma modulator and an incretin for the treatment of diabetes and obesity |
| 07/07/2011 | WO2011013999A3 Composition containing chitooligosaccharide for recovering from fatigue |
| 07/07/2011 | WO2011002258A9 Arginine-based amphiphilic peptide micelle |
| 07/07/2011 | WO2010151004A9 Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids |
| 07/07/2011 | WO2010139959A3 Alginate oligomers for the inhibition of microbial adherence to surfaces |
| 07/07/2011 | WO2010138010A8 Solvates of docetaxel |
| 07/07/2011 | WO2010111406A3 Purine derivatives useful as anti - cancer agents |
| 07/07/2011 | WO2010109176A3 Parenteral pharmaceutical composition for use in gene therapy |
| 07/07/2011 | WO2010089259A3 Sustained release composition containing quetiapine |
| 07/07/2011 | WO2010067008A3 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics |
| 07/07/2011 | WO2010067007A3 Synthesis of morphine-6-glucuronide or one of the derivatives thereof |
| 07/07/2011 | US20110166548 Drug releasing coatings for medical devices |
| 07/07/2011 | US20110166545 Apoptosis-inducing agent for prostate cancer cells |
| 07/07/2011 | US20110166409 Egfr and pten gene alterations predicts survival in patients with brain tumors |
| 07/07/2011 | US20110166237 Process for the Synthesis of Arformoterol |
| 07/07/2011 | US20110166234 Medicinal product and treatment |
| 07/07/2011 | US20110166233 Compounds for the treatment of metabolic disorders |
| 07/07/2011 | US20110166232 Enhancement of urogenital function |
| 07/07/2011 | US20110166231 Method of treating a human being for a class of metabolic defects and energy production disorders |
| 07/07/2011 | US20110166230 Method of treating a human being for a class of neurological defects and seizure disorders |
| 07/07/2011 | US20110166229 Prevention of psychotic disorders and/or treatment of psychotic symptoms |
| 07/07/2011 | US20110166228 Composition |
| 07/07/2011 | US20110166227 Balanced myristate- and laurate-containing edible oil |
| 07/07/2011 | US20110166226 Process for obtaining an extract rich in rosmarinic acid (ra) from the plant origanum vulgare and its use for the treatment of diabetes |
| 07/07/2011 | US20110166225 Oral liquid compositions of rhein or diacerein |
| 07/07/2011 | US20110166224 Diacylglycerol rich fats, oils and functional foods |
| 07/07/2011 | US20110166223 Methods of inhibiting fgfr3 signaling |
| 07/07/2011 | US20110166222 Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same |
| 07/07/2011 | US20110166221 Use of dronedarone for the preparation of a medicament for use in the prevention of cardioversion |
| 07/07/2011 | US20110166220 Dronedarone for the prevention of permanent atrial fibrillation |
| 07/07/2011 | US20110166219 Use of a polyphenol for the treatment of a cancerous or precancerous lesion of the skin |
| 07/07/2011 | US20110166218 Methods for micronization of hydrophobic drugs |
| 07/07/2011 | US20110166217 Pharmaceutical composition for prevention and/or treatment of bone loss |
| 07/07/2011 | US20110166216 Compositions and Methods for Inhibiting Growth and Metastasis of Melanoma |
| 07/07/2011 | US20110166215 Methods of improving the pharmacokinetics of doxepin |
| 07/07/2011 | US20110166214 Methods and compositions for delivery of taxanes in stable oil-in-water emulsions |
| 07/07/2011 | US20110166213 Method for obtaining oligonucleotide aptamers and uses thereof |